Pirouette Pharma
Pirouette Pharma is a clinical-stage pharmaceutical company focused on simplifying chronic injectable care with the development of a patient-centric, hidden-needle auto-injector platform for self-administration of essential medicines at home or in high-stress settings. Leveraging engineering, automation, and regulatory expertise, the company’s mission is to improve adherence, persistence, and comfort for chronic and rescue therapies while enabling scalable manufacturing in the United States. Pirouette partners with pharmaceutical companies for the co-development and distribution of both novel and established injectables using abbreviated FDA regulatory pathways.
Industries
N/A
Pirouette Pharma
200 International Dr. STE 170-180, Portsmouth, NH 03801
Pirouette Pharma is currently seeking investment
Pirouette Pharma is seeking a series-b investment in the range of 50m-plus
Patents
Products
Disc-shaped, push-button, automatic injection system with a completely hidden needle and controlled insertion; designed for prefilled single-use delivery of chronic and rescue injectables.
Disc-shaped, push-button, automatic injection system with a completely hidden needle and controlled insertion; designed for prefilled single-use delivery of chronic and rescue injectables.
Expertise Areas
- Injectable drug delivery systems
- Human factors engineering
- Regulatory compliance for combination products
- Automation in medical device manufacturing
Key Technologies
- Automatic needle-retracting injection mechanism
- Human factors engineering for drug delivery
- Environmental ruggedization for devices
- Automated device assembly and packaging
Key People
Conor R. Cullinane, PhD
Co‑Founder, Chairman, CEO, President, Principal Investigator
Matthew J. Kane, M.Sc.
Co-Founder, Secretary, Chief Operating Officer
Elijah M. Kapas
Co-Founder, Chief Technology Officer
Kevin Statz
Chief Commercial Officer
Emily Deane
VP of Quality
Matthew Fox
Chief of Staff
Conor R. Cullinane, PhD
Co‑Founder, Chairman, CEO, President, Principal Investigator
Matthew J. Kane, M.Sc.
Co-Founder, Secretary, Chief Operating Officer
Elijah M. Kapas
Co-Founder, Chief Technology Officer
Kevin Statz
Chief Commercial Officer
Emily Deane
VP of Quality
Matthew Fox
Chief of Staff
News & Updates
Naloxone auto-injector named Product of the Year by the New Hampshire Tech Alliance.
Featured by NIH SEED for safer, easier auto-injections at the BIO International 2024 event.
Pirouette Pharma presented innovation at the New Hampshire MedTech Lightning Showcase in Nashua.
Investor community update highlighted progress in platform development, operational and manufacturing advances, and quality systems improvements.
$4.3M raised in a second community round, with 70% returning investors and additional investment from Safar Partners.
Company update included IND filing, expansion of manufacturing, and leadership team growth.
Naloxone auto-injector named Product of the Year by the New Hampshire Tech Alliance.
Featured by NIH SEED for safer, easier auto-injections at the BIO International 2024 event.
Pirouette Pharma presented innovation at the New Hampshire MedTech Lightning Showcase in Nashua.
Investor community update highlighted progress in platform development, operational and manufacturing advances, and quality systems improvements.
$4.3M raised in a second community round, with 70% returning investors and additional investment from Safar Partners.
Company update included IND filing, expansion of manufacturing, and leadership team growth.